Your Complete Wegovy and Mounjaro Switching Guide
Why Patients Switch Between Wegovy and Mounjaro
Switching between Wegovy and Mounjaro has become increasingly common as patients and prescribers optimise weight management strategies. The primary reasons include side effect profiles, medication availability, cost considerations, and individual treatment response. Wegovy (semaglutide) works as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) acts on both GIP and GLP-1 receptors as a dual agonist. Some patients find one mechanism suits their body better than the other, leading to improved tolerance or effectiveness.
The switching process requires careful clinical oversight, as both medications have different dose escalation schedules and potency profiles. Your prescriber will determine appropriate dose conversions and timing to ensure a smooth transition. At EverydayMeds, our clinical team regularly manages switches between Wegovy and Mounjaro, providing continuity of care regardless of which prescription-only medicine you're prescribed. This expertise ensures your weight management journey continues without interruption or unnecessary complications.
Wegovy and Mounjaro Pricing Comparison
Understanding the cost implications when switching between Wegovy and Mounjaro helps inform your decision-making process. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. These prices reflect our final costs after applying discount codes FIRST40 for new customers or DOSE25 for returning patients at checkout. Mounjaro follows a different pricing structure due to its dual-agonist formulation and distinct dosing protocol.
Our bundle options provide additional convenience when planning your switching strategy. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg Wegovy) costs £299.99, supporting a gradual transition if moving from Mounjaro. The Progress Trio (0.5mg, 1mg, 1.7mg) at £369.99 suits patients switching at intermediate doses. These bundles ensure uninterrupted supply during your transition period, eliminating concerns about medication availability whilst your body adjusts to the new treatment.
Clinical Evidence for Wegovy and Mounjaro Switching
Clinical studies demonstrate that both Wegovy and Mounjaro can be effective components of comprehensive weight management programmes when used alongside reduced-calorie diets and increased physical activity. The STEP trials showed that patients taking Wegovy achieved an average of approximately clinically studied weight loss at 68 weeks, whilst SURMOUNT studies indicated similar effectiveness for Mounjaro. However, individual responses vary significantly, which is why switching between treatments may be clinically appropriate.
Research published by Wilding et al. in NEJM, 2021, established the robust clinical foundation for GLP-1 receptor agonists in weight management. When switching between Wegovy and Mounjaro, prescribers consider factors including previous weight loss response, side effect tolerance, and individual patient circumstances. Both medications require ongoing clinical monitoring to optimise outcomes and ensure safety throughout any transition period.
How Wegovy Works Compared to Mounjaro
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood sugar and appetite. It works primarily by slowing gastric emptying, which promotes feelings of fullness after smaller meals and reduces overall caloric intake. The medication also acts on brain appetite centres, potentially reducing food cravings and helping patients maintain dietary changes more easily. This mechanism makes Wegovy particularly effective when combined with behavioural interventions and lifestyle modifications. Unlike Mounjaro's dual-receptor approach, Wegovy's single-target mechanism provides a well-established pathway for weight management with extensive clinical experience supporting its use.
Seamless Ordering Process for Wegovy and Mounjaro
Switching between Wegovy and Mounjaro through EverydayMeds involves a streamlined process designed for patient convenience and safety. Begin with our 3-minute online clinical assessment, which captures your medical history, current medications, and switching rationale for prescriber review. Our qualified prescribers evaluate your application within standard 3 working days, or opt for express 24-hour review if you need faster medication access during your transition. Once approved, your prescription receives next-day delivery through our temperature-controlled cold-chain system, ensuring medication integrity regardless of weather conditions. This efficient process minimises gaps in treatment when switching between these prescription-only medicines.
Storage and Practical Considerations for Wegovy and Mounjaro
Wegovy offers distinct storage advantages over Mounjaro, particularly for patients with active lifestyles or frequent travel requirements. Whilst both medications require refrigeration at 2-8°C before first use, Wegovy remains stable for up to 6 weeks at room temperature below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, providing greater flexibility for holidays, business travel, or busy schedules. The FlexTouch pen delivery system requires no reconstitution or mixing, making weekly injections straightforward regardless of which medication you're switching to or from. Dose escalation schedules differ between treatments, so your prescriber will provide specific guidance on timing and progression during any transition period.
Personalised Switching Strategies for Wegovy and Mounjaro
Individual switching protocols between Wegovy and Mounjaro depend on your current dose, treatment duration, and clinical response. Patients established on higher Mounjaro doses may start Wegovy at intermediate strengths rather than the standard 0.25mg initiation dose, though this requires careful prescriber assessment. Some patients benefit from a brief washout period between medications, whilst others transition directly to maintain treatment continuity.
Our clinical team works closely with your existing prescriber or provides comprehensive care throughout the switching process. This personalised approach ensures your transition between Wegovy and Mounjaro aligns with your individual medical needs and weight management goals. We maintain detailed treatment records to support optimal dosing decisions and monitor your progress effectively during any medication changes.
Start Your Wegovy and Mounjaro Switch Today
Ready to explore switching between Wegovy and Mounjaro with expert clinical support? Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discuss your switching options with our qualified prescribers. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our competitive pricing from £79.99. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medications with comprehensive patient support throughout your weight management journey. Don't let medication transitions disrupt your progress – let our experienced team guide you through a safe, effective switch between these proven prescription treatments. Contact us today to discuss which option might work best for your individual circumstances and treatment goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
